HIV/HCV prevention among people who inject drugs (PWID) is of key public health importance. We aimed to assess the impact of COVID-19 and associated response measures on HIV/HCV prevention services ...and socio-economic status of PWID in high-HIV-risk sites. Sites with recent (2011–2019) HIV outbreaks among PWID in Europe North America and Israel, that had been previously identified, were contacted early May 2020. Out of 17 sites invited to participate, 13 accepted. Semi-structured qualitative site reports were prepared covering data from March to May 2020, analyzed/coded and confirmed with a structured questionnaire, in which all sites explicitly responded to all 103 issues reported in the qualitative reports. Opioid maintenance treatment, needle/syringe programs and antiretroviral treatment /hepatitis C treatment continued, but with important reductions and operational changes. Increases in overdoses, widespread difficulties with food and hygiene needs, disruptions in drug supply, and increased homelessness were reported. Service programs rapidly reformed long established, and politically entrenched, restrictive service delivery policies. Future epidemic control measures should include mitigation of negative side-effects on service provision and socio-economic determinants in PWID.
Increased adiposity at birth may identify infants at high risk of developing obesity. Maternal obesity and hyperglycemia in pregnancy are associated with increased neonatal adiposity; however, ...features of maternal obesity that contribute to increased neonatal adiposity need further study.
To measure adiposity in neonates of obese and normal-weight women without gestational diabetes to test the hypothesis that obese women have neonates with increased adiposity compared to neonates of normal-weight women.
Sixty-one pregnant women, with a normal or obese BMI, and their neonates participated in this cross-sectional study at an academic medical center. Neonatal adiposity, expressed as percent body fat (fat mass/body mass), was measured by air displacement plethysmography and cord blood was assayed for biomarkers.
Adiposity in neonates of obese and normal-weight mothers did not differ. Stratifying mothers by leptin level showed that neonates born to mothers with higher leptin had significantly higher adiposity (13.2 vs. 11.1%, p = 0.035). In the entire cohort, adiposity positively correlated with cord blood leptin (r = 0.48, p < 0.001) and adiponectin (r = 0.27, p = 0.04) levels.
Obesity in normoglycemic pregnant women was not associated with increased neonatal adiposity. High maternal leptin levels identified neonates with increased adiposity.
We aimed to assess the effects of age, sex, body mass index (BMI), and anatomical site on skin thickness in children and adults with diabetes.
We studied 103 otherwise healthy children and ...adolescents with type 1 diabetes aged 5-19 years, and 140 adults with type 1 and type 2 diabetes aged 20-85 years. The thicknesses of both the dermis and subcutis were assessed using ultrasound with a linear array transducer, on abdominal and thigh skin.
There was an age-related thickening of both dermis (p<0.0001) and subcutis (p = 0.013) in children and adolescents. Girls displayed a substantial pubertal increase in subcutis of the thigh (+54%; p = 0.048) and abdomen (+68%; p = 0.009). Adults showed an age-related decrease in dermal (p = 0.021) and subcutis (p = 0.009) thicknesses. Pubertal girls had a thicker subcutis than pubertal boys in both thigh (16.7 vs 7.5 mm; p<0.0001) and abdomen (16.7 vs 8.8 mm; p<0.0001). Men had greater thigh dermal thickness than women (1.89 vs 1.65 mm; p = 0.003), while the subcutis was thicker in women in thigh (21.3 vs 17.9 mm; p = 0.012) and abdomen (17.7 vs 9.8 mm; p<0.0001). In boys, men, and women, both dermis and subcutis were thicker on the abdomen compared to thigh; in girls this was only so for dermal thickness. In both children and adults, the skin (dermis and subcutis) became steadily thicker with increasing BMI (p<0.0001).
Skin thickness is affected by age, pubertal status, gender, BMI, and anatomical site. Such differences may be important when considering appropriate sites for dermal/subcutaneous injections and other transdermal delivery systems.
Background and aims: Oral aminosalicylates are well established in the treatment of active mild/moderate ulcerative colitis (UC) when the disease is extensive (that is, beyond the splenic flexure). ...The majority of clinical symptoms relate to disease activity in the distal part of the colon and therefore this study was designed to investigate if adding a mesalazine enema to oral mesalazine has additional benefit for patients with extensive mild/moderate active UC. Methods: A randomised double blind study was performed in 127 ambulatory patients. All received 4 g/day (twice daily dosing) oral mesalazine for eight weeks. During the initial four weeks, they additionally received an enema at bedtime containing 1 g of mesalazine or placebo. Disease activity was assessed using the ulcerative colitis disease activity index, with clinical and endoscopic signs at four and eight weeks. Results: Remission was obtained in 44% (95% confidence interval (CI) 31%, 58%) of the mesalazine enema group (Me) and in 34% (95% CI 21%, 49%) of the placebo enema group (Pl) at four weeks (p = 0.31) and in 64% (95% CI 50%, 76%) of the Me group versus 43% (95% CI 28%, 58%) of the Pl group at eight weeks (p = 0.03). Improvement was obtained in 89% (95% CI 78%, 96%) of the Me group versus 62% (95% CI 46%, 75%) of the Pl group at four weeks (p = 0.0008) and in 86% (95% CI 75%, 94%) of the Me group versus 68% (95% CI 53%, 81%) of the Pl group at eight weeks (p = 0.026). Conclusion: In patients with extensive mild/moderate active UC, the combination therapy is superior to oral therapy. It is safe, well accepted, and may be regarded as firstline treatment.
Chili peppers (Capsicum spp.) are widely cultivated food plants that arose in the Americas and are now incorporated into cuisines worldwide. Here, we report a genus-specific starch morphotype that ...provides a means to identify chili peppers from archaeological contexts and trace both their domestication and dispersal. These starch microfossils have been found at seven sites dating from 6000 years before present to European contact and ranging from the Bahamas to southern Peru. The starch grain assemblages demonstrate that maize and chilies occurred together as an ancient and widespread Neotropical plant food complex that predates pottery in some regions.
IMPORTANCE Nail dystrophy in early childhood often suggests a diagnosis of pachyonychia congenita (PC). No previous investigation has focused on the early signs of PC and the natural course of the ...disease. OBJECTIVES To determine the course of pediatric PC, correlate the disease course with the clinical appearance and specific gene mutations, and assess the effect of pediatric PC on quality of life. DESIGN, SETTING, AND PARTICIPANTS One hundred one patients or families with genetically confirmed PC from the International Pachyonychia Congenita Research Registry who completed a survey on the general clinical features of PC and an auxiliary questionnaire on the clinical presentation and quality-of-life issues related to pediatric PC. EXPOSURE Individuals with pachyonychia congenita. MAIN OUTCOMES AND MEASURES Completion of both surveys. RESULTS At birth, toenail changes were present in 47.5% of patients; fingernail changes in 40.6%; and plantar keratoderma in 6.9%. By 5 years of age, these 3 key manifestations were found in 81.2%, 74.2%, and 75.3%, respectively, of individuals with genotype-confirmed PC. The correct diagnosis was made during the first year of life in 26.7% of patients despite the presence of toenail dystrophy in more than 65.3%. Clinical differences that distinguished PC subtypes included (1) later onset and less frequent occurrence of nail dystrophy and keratoderma in PC-K6b, PC-K6c, and PC-K16; (2) concurrent fingernail and toenail thickening in PC-K6a and PC-K17; (3) more palmar keratoderma in PC-K16; (4) cysts primarily in PC-K17 and follicular hyperkeratoses primarily in PC-K6a; (5) hoarseness and/or oral leukokeratoses in the first year of life most often in PC-K6a; and (6) natal teeth exclusively in PC-K17. Among pediatric patients, PC affected the social interactions and function of adolescents most profoundly. CONCLUSIONS AND RELEVANCE Among patients with a detectable mutation, PC manifests with nail thickening and plantar keratoderma before school age in more than three-quarters of affected children, allowing early diagnosis. The highly visible nail changes and painful plantar thickening exert a psychosocial effect on most affected adolescents. Phenotype-genotype correlations in children with PC validate the new classification based on the affected gene.
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Conducting systematic annotation and ablation of evoked delayed potentials (EDP) in response to short coupled right ...ventricular extra-stimuli (RV-ES) has improved ablation outcome of post myocardial infarction (MI) ventricular tachycardia (VT). The reported short radiofrequency catheter ablation (RFCA) times suggests the presence of predilection areas for these functional substrates.
Purpose
To evaluate the electroanatomical characteristics and distribution of EDPs in post-MI patients referred for RFCA of VT.
Methods
Electroanatomical mapping (EAM) data of 48 post-MI patients (69 ± 9 years, 39 male, LV ejection fraction 36 ± 10%, anterior MI 20 42%, inferior MI 28 58%), who underwent functional substrate mapping and ablation were analyzed. Pre-procedural cardiac CTs of 16 patients (8 anterior, 8 inferior MI) were integrated with EAM data. Infarct extension (defined as bipolar voltage BV <3.0mV, dense scar <0.5mV and scar borderzone BZ 0.5-3mV) and EDP location were determined based on the AHA 17-segment model of the left ventricle.
Results
RV-ES was performed during mapping at 2180 LV sites (median 46 per patient, range 8-81) and EDPs were observed at 631 (29%) sites. Patients had a median of 11 (range 1-37) EDP sites. Compared to no-EDP sites, EDP sites had lower BV (median 0.57 mV vs. 0.77 mV, P <0.001), longer duration (median 79 ms vs. 66 ms, P <0.001), and larger number of positive sharp deflections (median 6 vs. 5, P <0.001) during sinus rhythm. Of all EDP sites, 278 (44%), 286 (45%), 64 (10%), and 3 (1%) had BV of <0.5mV, ≥ 0.5mV and <1.5 mV, a BV of ≥1.5 mV and <3.0 mV, and a BV of >3.0 mV, respectively. In the 16 patients with CT image integration, a total of 124/272 segments showed EA scar with a median (IQR, range) of 8 (6-9, 4-12) segments per patient. Any EDP was identified in 71/124 (57%) of segments with EA scar. Of note, 73% of all EDPs in inferior MIs and 64% of all EDPs in anterior MI were located in 4 AHA segments, namely 3,4, 9,10 and 7,8,13,14, respectively, close to the inferior or anterior RV insertion. Such a cluster of EDP sites around the RV insertion was found in 6 (75%) patients with inferior MI and in 7 (88%) patients with anterior MI.
Conclusion
About 10% of EDPs are identified at sites with BV of ≥1.5mV and <3.0mV during sinus rhythm supporting the recently proposed BV threshold <3.0mV for post-MI scars. EDPs are frequently located near the RV insertion in both inferior MI and anterior MI suggesting a role of the RV insertion in the functional substrate of post-MI VT.
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Patients with ischemic cardiomyopathy (ICM) and monomorphic, sustained ventricular tachycardia (VT) are considered to be ...at risk for arrhythmia-related sudden cardiac death (SCD). Prior studies have suggested that patients with well-tolerated VTs and preserved or moderately reduced left ventricular ejection fraction (LVEF) and successful VT ablation may not benefit from cardioverter defibrillator implantation (ICD Current guidelines indicate that in selected patients catheter ablation should be considered instead of ICD, but supporting evidence is limited.
Aim
This study aims to analyze arrhythmia outcomes of ICM patients referred for VT ablation without prior ICD implantation according to LVEF, hemodynamical stability during VT and ablation outcome.
Methods
ICM patients without prior ICD implantation undergoing VT ablation in a tertiary center between 2009 and 2022 were included. Patients who presented with a first episode of tolerated VT and w a LVEF≥35% were offered catheter ablation (CA) as first-line therapy. Patients were categorized according to (1) LVEF, (2) clinical presentation (hemodynamically tolerated/non-tolerated VT) and (3) acute ablation outcome. According to the institutional protocol, ICD was offered to all patients after ablation, but was subject to shared decision making, explaining the available evidence supporting ICDs for the different categories.
Results
Eighty-six ICM patients without ICD underwent ablation for VT. Mean age was 69±9 years and 72 (84%) were men, mean LVEF was 41±9% and 34 patients (28%) were using anti-arrhythmic drugs (AAD). The median VT cycle length (VTCL) at presentation was 323ms 300 – 375 and VT was tolerated in 58 (67%) patients (median tolerated VTCL 325ms 300 – 371). In 66 (77%) patients, the LVEF was ≥35% of which 51 had well-tolerated VT. Of these 51 patients, 37 (73%) were rendered non-inducible after ablation and in 14 patients non-clinical VTs remained inducible (median remaining VTCL 238ms 203-288). In 5/37 non-inducible and in 11/14 inducible patients, an ICD was implanted. Of the 35 patients who had LVEF<35% and/or non-tolerated VTs, 7 refused ICD implantation. (Figure 1)
During a median follow-up of 35 22 – 53 months, 10 patients (12%) had VT-recurrence and one patient with an ICD had SCD. Mortality was 22%. In the 37 patients with LVEF≥35%, tolerated VT and non-inducibility post procedure, no SCD or VT-recurrence was observed. Also, in this group no patient was using AAD for VT at last follow-up. In the 14 remaining patients with LVEF≥35% and tolerated VT who were still inducible after ablation, no SCD occurred but VT recurred in 29% (median VTCL 303ms 200-374) with AAD-use for VT in 29%.
Conclusion
This study supports that ICM patients without prior ICD and LVEF≥35% who present with hemodynamically well-tolerated VT and are non-inducible after ablation have an excellent prognosis. Successful CA without ICD implantation seems to be safe in these selected patients.
Management of presented patients